Loading stock data...

Bharat Parenterals Limited

BSE: BPLPHARMA

BSE
1,232.00 22.00 (1.82%)

Prev Close

1210

Open Price

1203.4

Volume

1,880

Today Low / High

1203.4 / 1272

52 WK Low / High

802 / 1667.2

Range

1,170 - 1,294

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1232, reflecting a change of 22 (1.81818%). The expected target range on the BSE is 1,170 - 1,294. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

01 Jan 1,211.05 -0.09%
31 Dec 1,215.00 -0.46%
30 Dec 1,272.00 -4.96%
29 Dec 1,262.15 -4.37%
26 Dec 1,249.00 1.53%
24 Dec 1,217.95 0.34%
23 Dec 1,224.00 -0.49%
22 Dec 1,180.00 3.21%
19 Dec 1,200.00 -2.00%
18 Dec 1,184.00 2.15%
17 Dec 1,125.00 5.33%
16 Dec 1,118.00 2.41%
15 Dec 1,051.05 6.36%
12 Dec 1,098.65 2.74%
11 Dec 1,100.00 -3.55%
10 Dec 1,125.00 -2.23%
09 Dec 1,083.70 1.61%
08 Dec 1,070.00 1.79%

Bharat Parenterals Limited Graph

Bharat Parenterals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Bharat Parenterals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,232.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,232.00 1,244.32 1,119.89 - 1,368.75
1,256.64 1,005.31 - 1,507.97
1,268.96 888.27 - 1,649.65
Bearish Scenario 1,232.00 1,219.68 1,097.71 - 1,341.65
1,207.36 965.89 - 1,448.83
1,195.04 836.53 - 1,553.55

Overview of Bharat Parenterals Limited

ISIN

INE365Y01019

Industry

Medical - Pharmaceuticals

Vol.Avg

772

Market Cap

8,339,275,230

Last Dividend

1

Official Website

Visit Website

IPO Date

DCF Diff

3,499.38

DCF

-1,745

Financial Ratios Every Investor Needs

Stock Dividend of BPLPHARMA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-19 September 19, 25 1 1 2025-09-19 2025-10-26
2024-06-25 June 25, 24 1 1 2024-06-25 2024-08-01
2023-09-25 September 25, 23 0.75 0.75 2023-09-25 2023-10-30

Stock Rating Details for BPLPHARMA

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 340.38 Cr 185.48 Cr 154.90 Cr 0.4551 6.51 Cr 49.66 Cr -32.62 Cr -12.63 Cr -18.33 14.32 Cr -0.0371
2024-03-31 257.05 Cr 168.24 Cr 88.80 Cr 0.3455 1.06 Cr 6.13 Cr 17.18 Cr 14.52 Cr 24.94 26.57 Cr 0.0565
2023-03-31 217.98 Cr 174.96 Cr 43.02 Cr 0.1974 1.05 Cr 18.00 Cr 15.34 Cr 16.44 Cr 28.47 25.72 Cr 0.0754
2022-03-31 212.01 Cr 168.43 Cr 43.58 Cr 0.2056 1.42 Cr 18.72 Cr 22.78 Cr 21.05 Cr 36.67 35.51 Cr 0.0993
2021-03-31 204.64 Cr 164.32 Cr 40.32 Cr 0.1970 1.71 Cr 17.93 Cr 20.02 Cr 20.39 Cr 35.59 27.52 Cr 0.0996

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.56 Cr 648.53 Cr 309.53 Cr 330.6700 Cr 180.20 Cr 179.64 Cr 71.95 Cr 229.10 Cr 0.00 Cr 0.00 Cr 1.52 Cr 219.3000 Cr
2024-03-31 8.71 Cr 503.82 Cr 265.65 Cr 197.2668 Cr 157.58 Cr 148.87 Cr 61.47 Cr 233.37 Cr 0.00 Cr 0.00 Cr 2.42 Cr 190.3838 Cr
2023-03-31 8.91 Cr 351.37 Cr 133.47 Cr 182.7963 Cr 49.74 Cr 40.83 Cr 37.84 Cr 160.86 Cr 7.46 Cr 0.00 Cr 3.53 Cr 119.7982 Cr
2022-03-31 4.66 Cr 226.88 Cr 56.74 Cr 165.8250 Cr 17.75 Cr 13.08 Cr 20.76 Cr 76.65 Cr 2.11 Cr 0.00 Cr 3.42 Cr 41.5309 Cr
2021-03-31 2.42 Cr 198.94 Cr 55.12 Cr 143.8658 Cr 12.24 Cr 9.82 Cr 22.43 Cr 45.07 Cr 1.18 Cr 0.00 Cr 4.73 Cr 43.6255 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -27.2500 Cr -137.1100 Cr 156.0900 Cr -56.3300 Cr -8.2700 Cr 0.4400 Cr -29.0800 Cr -33.9500 Cr 22.6100 Cr -0.5800 Cr -10.4800 Cr
2024-03-31 -4.7057 Cr -104.7840 Cr 110.4276 Cr -109.0078 Cr 0.9380 Cr 8.7791 Cr -104.3021 Cr 14.5171 Cr 107.8356 Cr -0.4331 Cr -23.6255 Cr
2023-03-31 21.6638 Cr -77.8194 Cr 60.5979 Cr -70.8262 Cr 4.2474 Cr 8.9108 Cr -91.6007 Cr 16.4404 Cr -1.2438 Cr 0.0000 Cr -17.0818 Cr
2022-03-31 -1.6335 Cr -2.5956 Cr 5.9512 Cr -40.5857 Cr 2.2476 Cr 4.6634 Cr -38.9522 Cr 21.0528 Cr 1.1789 Cr 0.0000 Cr 1.6723 Cr
2021-03-31 24.4475 Cr -43.3718 Cr 10.4984 Cr 24.7517 Cr -7.9703 Cr 2.4158 Cr -5.8615 Cr 20.3892 Cr 9.7473 Cr 0.0000 Cr 6.3830 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 64.62 Cr 26.92 Cr 37.70 Cr 0.5834 -7.74 Cr -7.24 Cr -14.00 4.36 Cr -0.1120
2025-06-30 116.00 Cr 68.85 Cr 47.15 Cr 0.4065 5.18 Cr 8.23 Cr 11.94 14.84 Cr 0.0709
2025-03-31 103.98 Cr 53.54 Cr 50.44 Cr 0.4851 -6.29 Cr -4.72 Cr -6.85 4.16 Cr -0.0454
2024-12-31 72.26 Cr 35.67 Cr 36.59 Cr 0.5064 -5.11 Cr -1.68 Cr -2.44 6.59 Cr -0.0232
2024-09-30 71.63 Cr 61.33 Cr 10.30 Cr 0.1438 -16.68 Cr -7.51 Cr -11.51 -3.46 Cr -0.1048

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 5.07 Cr 18.05 Cr 23.12 Cr 141.99 Cr 71.70 Cr 287.70 Cr 221.09 Cr 575.28 Cr 246.42 Cr
2025-06-30 0.00 Cr 0.00 Cr 62.57 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -339.00 Cr
2025-03-31 0.56 Cr 67.43 Cr 67.99 Cr 171.84 Cr 71.95 Cr 355.51 Cr 229.10 Cr 648.53 Cr 309.53 Cr
2024-12-31 0.00 Cr 0.00 Cr 39.77 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -304.02 Cr
2024-09-30 8.81 Cr 35.29 Cr 44.10 Cr 159.24 Cr 39.54 Cr 278.63 Cr 228.14 Cr 541.83 Cr 237.81 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 8.23 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -4.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -1.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -7.51 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹806.70 ₹96,616,600,363.00 ₹121,137.00

Key Executives

Director of Strategy & Investor Relations
Bhahim Desai

Gender: male

Year Born:

Chairman & MD
Bharatkumar Rameshchandra Desai

Gender: male

Year Born: 1934

Executive Director
Hemang Jayandrabhai Shah

Gender: male

Year Born: 1968

Chief Financial Officer
Jignesh Nitinchandra Shah

Gender: male

Year Born:

Company Secretary & Compliance Officer
Sharmin Nareshkumar Soni

Gender: male

Year Born:

President of Commercial
Himaben Bharatbhai Desai

Gender: female

Year Born: 1968

Marketing Manager
Nikita Bhahim Desai

Gender: female

Year Born:

FAQs about Bharat Parenterals Limited

Who is the CEO of the company?

The CEO is Bharatkumar Rameshchandra Desai.

What is the current market price of the stock?

The current price is ₹1,210.00.

What is the 52-week price range?

The range is ₹802-1667.2.

What is the market capitalization of the company?

The market capitalization is ₹833.93 crores.

What is the dividend yield?

The dividend yield is 0.08%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -115.66.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Bharat Parenterals Limited (ISIN: INE365Y01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹833.93 crores and an average daily volume of 772 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹1.